Doctors Worry About Shortage of Pluvicto Medication for Prostate Cancer Patients Novartis AG is trying to boost the availability of life-extending treatment Pluvicto for advanced prostate cancer patients, but some may have to wait months. by Trisha Kae Andrada
EU Data Protection Task Force Examines OpenAI's ChatGPT Privacy Compliance, Reveals Preliminary Findings